Anemia, Sickle Cell: all 1,125 studies
Page 6 of 12. Open to participants first (238), then studies with results posted, then the rest; newest registration first within each.
- Real World Patient Characteristics and Treatment Patterns From Crizanlizumab Use: Preliminary Analysis From Select Sickle Cell CentersCompletedNCT06662825
- Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery RegistryCompletedNCT06662812
- Cohort Study of Sickle Cell Patients Evaluating Analgesic Strategies and Their ConsequencesCompletedNCT06650059
- HEMAGO Monitoring and Impact on the Occurrence of Complications During Pregnancy in Sickle Cell PatientsCompletedNCT06620887
- A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese ParticipantsCompletedNCT06581627Phase 1
- The Feasibility of the Pray Until Something Happens (PUSH) Intervention-OUTPATIENTCompletedNCT06580067Not applicable
- Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) InterventionWithdrawnNCT06562439Not applicable
- Zinc for Infection Prevention in Sickle Cell Anemia-2 (ZIPS-2)CompletedNCT06561061Phase 2/3
- Acupressure in Patients With Sickle Cell DiseaseActive, not recruitingNCT06511453Not applicable
- A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell ParticipantsTerminatedNCT06503458
- LEARNER- Low dosE AspiRiN prEterm tRial (Angola)Active, not recruitingNCT06417411Phase 1/2
- Prevention of Malnutrition in Children With Sickle Cell DiseaseCompletedNCT06397118Not applicable
- The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related RetinopathyCompletedNCT06396403
- Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell DiseaseCompletedNCT06345638
- Effect of Empowerment-Based Interventions on Self-Efficacy and Self-Care Capacity Among Adults With Sickle Cell DiseaseCompletedNCT06296654Not applicable
- Patient and Public Involvement and Engagement in Research With Children and Young People With Sickle Cell Disorder and Their FamiliesActive, not recruitingNCT06293222
- A Study of Mitapivat in Participants With Sickle Cell Disease and NephropathyWithdrawnNCT06286046Phase 2
- High Dose Vitamin D Supplementation in Children With Sickle Cell DiseaseCompletedNCT06274203Not applicable
- Applying Directly Observed Therapy to Hydroxyurea to Realize EffectivenessCompletedNCT06264700Not applicable
- Support Strategies for Parents During the First Year Following Their Child's Diagnosis of Sickle Cell DisorderCompletedNCT06251843
- Realizing Effectiveness Across Continents With HydroxyureaActive, not recruitingNCT06171217Phase 2
- Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)Active, not recruitingNCT06155500Phase 1
- A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)CompletedNCT06144749Phase 2
- The Sequestration of Holistic Stress Management Techniques for AdultsWithdrawnNCT06098755Not applicable
- Sickle Cell Children's Exercise Study (SuCCESs)Active, not recruitingNCT06074198Not applicable
- Assessing Physical Function in Sickle Cell Patients Taking VoxelotorCompletedNCT06023199Phase 2
- GenoMed4ALL: Improving SCD Classification and Prognosis by AIActive, not recruitingNCT06019208
- COVID-19 Vaccination Hesitancy in Adults With Sickle Cell DiseaseCompletedNCT05998824Not applicable
- VO2max & HRQoL in Children With Sickle Cell DiseaseCompletedNCT05995743
- Steroid Injection for Sickle Cell Arthropathy Pain TherapyCompletedNCT05983055
- Effect of Virtual Reality on Pain and Function in Children With Sickle Cell Disease: A Randomized Controlled TrialCompletedNCT05952817Not applicable
- Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/ βC GenotypeWithdrawnNCT05951205Phase 3
- Efficacy of Designed Exercise Program on Pain and Quality of Sleeping in Patient With Sickle Cell Disease Anemia.CompletedNCT05894161Not applicable
- Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell DiseaseCompletedNCT05861453Phase 2
- Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease PatientStatus unknownNCT05848531Phase 4
- Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell CentersCompletedNCT05833022
- Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease PatientsCompletedNCT05791591Not applicable
- Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD)CompletedNCT05789355Not applicable
- Lipid Balance in Adult Sickle Cell PatientsActive, not recruitingNCT05780775Not applicable
- Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell DiseaseActive, not recruitingNCT05758766Not applicable
- ORCHARD- Optimising Home Assessment of Rural PatientsCompletedNCT05732922Not applicable
- Effects of the Contraceptive Implant in Women With Sickle Cell DiseaseActive, not recruitingNCT05730205Phase 4
- Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell DiseaseCompletedNCT05725902Phase 2
- Baby Detect : Genomic Newborn ScreeningCompletedNCT05687474
- Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in KinshasaCompletedNCT05681598Not applicable
- Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell DiseaseActive, not recruitingNCT05675436
- Alternative Dosing And Prevention of Transfusions (ADAPT)Active, not recruitingNCT05662098Early Phase 1
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 YearsTerminatedNCT05660265Phase 1
- Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease PatientsCompletedNCT05649280
- Inflammation, Platelets and Sickle Cell DiseaseActive, not recruitingNCT05646888
- Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)CompletedNCT05618301Phase 1
- Mindfulness and Yoga Therapy for Acute Pain in Sickle Cell DiseaseCompletedNCT05572294Not applicable
- Pilates Physical Activity in Sickle Cell DiseaseStatus unknownNCT05519852Not applicable
- Characteristics of Patients With Sickle Cell DiseaseCompletedNCT05494541
- L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet VelocityCompletedNCT05470998Phase 3
- Acceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease.CompletedNCT05470270Phase 2
- Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)SuspendedNCT05457790Not applicable
- BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell DiseaseActive, not recruitingNCT05456880Phase 1/2
- "Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell Disease"DiseaseCompletedNCT05407740
- Research Study Investigating How Well NDec Works in People With Sickle Cell DiseaseCompletedNCT05405114Phase 2
- Low Dose Iron Chelation as TReatment of Oxidative Damage in Sickle Cell DiseaseCompletedNCT05392101Phase 2
- Hemoglobinopathy Nursing Program and Pediatric Nursing StudentsCompletedNCT05389891Not applicable
- DSUVIA in Patients With SCD VOC Present in the EDStatus unknownNCT05388188
- TMLI and Alemtuzumab for Treatment of Sickle Cell DiseaseActive, not recruitingNCT05384756Phase 1
- Oral Ketamine for Treatment of Vaso-Occlusive PainCompletedNCT05378555Phase 1
- Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD PatientsCompletedNCT05371184Phase 4
- Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-ThalassemiaActive, not recruitingNCT05357482Phase 1/2
- A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)Active, not recruitingNCT05353647Phase 2
- A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell DiseaseTerminatedNCT05348915Phase 3
- The Montreal Cognitive Assessment.Test in Adults With Sickle Cell DiseaseCompletedNCT05347043Not applicable
- Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)Active, not recruitingNCT05329649Phase 3
- CHOICES3: Sickle Cell Disease Parenting CHOICESActive, not recruitingNCT05292781Not applicable
- Red Blood Cell - IMProving trAnsfusions for Chronically Transfused RecipientsCompletedNCT05255445
- Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)CompletedNCT05253781Phase 3
- Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD PatientsCompletedNCT05249452
- Voxelotor Brain Oxygenation and Neurocognitive StudyWithdrawnNCT05228821Phase 4
- SCD Fit Homebase ProgramWithdrawnNCT05228756Not applicable
- Screening for Renal Complications in Children and Young Adults With Major Sickle Cell DiseaseCompletedNCT05211037Not applicable
- Avascular Bone Necrosis in Sickle Cell Disease: a Pediatric Study.CompletedNCT05203991
- Nasopharyngeal Bacterial Carriage and Antibiotic Resistance in Children With Sickle Cell Disease in Ile-De-FranceStatus unknownNCT05197205Not applicable
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PociredirCompletedNCT05169580Phase 1
- Cooperative Assessment of Late Effects for SCD Curative TherapiesActive, not recruitingNCT05153967
- Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-FranceStatus unknownNCT05153044Not applicable
- Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.Active, not recruitingNCT05145062
- Sickle Cell Disease Obstetric Multi-Disciplinary Care ProgrammeActive, not recruitingNCT05143021
- A Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot StudyCompletedNCT05142254Phase 2
- Telemedicine for Children With Sickle Cell DiseaseCompletedNCT05087303Not applicable
- Interest of Famotidine in Children With Sickle Cell DiseaseCompletedNCT05084521Phase 2/3
- Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell AnemiaCompletedNCT05081349Phase 4
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)CompletedNCT05075824Phase 2
- Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell AnemiaCompletedNCT05053932
- Moya Moya Syndrome With or Withtout Sickle Cell DiseaseStatus unknownNCT05050344
- Integrative Medicine in Pain Management in Sickle Cell DiseaseActive, not recruitingNCT05045820Not applicable
- A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy ParticipantsCompletedNCT05036512Phase 1
- THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)TerminatedNCT05033314Phase 3
- A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)Active, not recruitingNCT05031780Phase 2/3
- Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and IndiaTerminatedNCT05020873
- Losartan for Diffuse Myocardial Fibrosis in Sickle Cell DiseaseCompletedNCT05012631Phase 2
- A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseCompletedNCT04987489Phase 2
- Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell DiseaseCompletedNCT04983654Not applicable